ZHAO; Baowei
Patent Applications and Registrations
Patent applications and USPTO patent grants for ZHAO; Baowei.The latest application filed is for "1,2,3,4-tetrahydroquinoxaline derivative, preparation method therefor and application thereof".
- ZHAO; Baowei - Pudong New Area Shanghai
- Zhao; Baowei - Shanghai CN
| Patent | Date |
|---|---|
| 1,2,3,4-tetrahydroquinoxaline Derivative, Preparation Method Therefor And Application Thereof App 20220009894 - ZHAO; Baowei ; et al. | 2022-01-13 |
| Nitrogen heteroaryl derivative having CSF1R inhibitory activity, and preparation method therefor and application thereof Grant 11,180,495 - Zhang , et al. November 23, 2 | 2021-11-23 |
| N-(azaaryl)cyclolactam-1-carboxamide derivative, preparation method therefor, and use thereof Grant 11,149,021 - Zhao , et al. October 19, 2 | 2021-10-19 |
| Azaaryl derivative, preparation method therefor, and application thereof for use in pharmacy Grant 11,130,762 - Zhao , et al. September 28, 2 | 2021-09-28 |
| Compounds for inhibiting LRRK2 kinase activity Grant 11,034,696 - Ren , et al. June 15, 2 | 2021-06-15 |
| Compounds App 20210130339 - REN; Feng ; et al. | 2021-05-06 |
| Substituted fused pyrazole compounds and their use as LRRK2 inhibitors Grant 10,975,081 - Ding , et al. April 13, 2 | 2021-04-13 |
| Compounds Grant 10,858,367 - Ding , et al. December 8, 2 | 2020-12-08 |
| Azaaryl Derivative, Preparation Method Therefor, And Application Thereof For Use In Pharmacy App 20200165254 - ZHAO; Baowei ; et al. | 2020-05-28 |
| Nitrogen Heteroaryl Derivative Having Csf1r Inhibitory Activity, And Preparation Method Therefor And Application Thereof App 20200140431 - ZHANG; Mingming ; et al. | 2020-05-07 |
| LRRK2 inhibitors for the treatment of Parkinson's disease Grant 10,618,901 - Ding , et al. | 2020-04-14 |
| Compounds App 20200079777 - DING; Xiao ; et al. | 2020-03-12 |
| N-(azaaryl)cyclolactam-1-carboxamide Derivative, Preparation Method Therefor, And Use Thereof App 20200071302 - ZHAO; Baowei ; et al. | 2020-03-05 |
| Compounds App 20190389850 - REN; Feng ; et al. | 2019-12-26 |
| Compounds App 20190359623 - DING; Xiao ; et al. | 2019-11-28 |
| Compounds For Inhibiting Lrrk2 Kinase Activity App 20190359618 - REN; Feng ; et al. | 2019-11-28 |
| Compounds App 20180354956 - Ding; Xiao ; et al. | 2018-12-13 |
| Compounds App 20170015668 - DING; Xiao ; et al. | 2017-01-19 |
| Heterocyclic compounds Grant 8,389,508 - Deng , et al. March 5, 2 | 2013-03-05 |
| 1,2,4-oxadiazole indole compounds Grant 8,217,028 - Castro Pineiro , et al. July 10, 2 | 2012-07-10 |
| 5-membered Heteroaryl Derivatives Used As Sphingosine 1-phosphate Receptor Agonists App 20120101134 - Deng; Guanghui ; et al. | 2012-04-26 |
| Compounds App 20110269738 - Deng; Guanghui ; et al. | 2011-11-03 |
| Compounds App 20110086839 - Castro Pineiro; Jose Luis ; et al. | 2011-04-14 |
| Compounds App 20100029729 - Castro Pineiro; Jose Luis ; et al. | 2010-02-04 |
| Compounds App 20100010053 - Castro Pineiro; Jose Luis ; et al. | 2010-01-14 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 